Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for atrial fibrillation in Portugal

• Published in: Revista portuguesa de cardiologia Vol. 34; no. 12; pp. 723 - 737
• Main Authors: Costa, João, Fiorentino, Francesca, Caldeira, Daniel, Inês, Mónica, Lopes Pereira, Catarina, Pinheiro, Luís, Vaz-Carneiro, António, Borges, Margarida, Gouveia, Miguel
• Format: Journal Article
• Language: English; Portuguese
• Published: Portugal 01.12.2015
• Subjects: Anticoagulants - therapeutic use; Atrial Fibrillation - drug therapy; Benzimidazoles - economics; Benzimidazoles - therapeutic use; Cost-Benefit Analysis; Dabigatran - economics; Dabigatran - therapeutic use; Humans; Portugal; Pyrazoles - economics; Pyrazoles - therapeutic use; Pyridones - economics; Pyridones - therapeutic use; Stroke - drug therapy; Warfarin - therapeutic use; Anos de vida ajustados pela qualidade; Anticoagulantes orais; Atrial fibrillation; Fibrilhação auricular; Oral anticoagulants; Quality‐adjusted life years; Custo‐efetividade; Cost‐effectiveness

Recently, three novel non-vitamin K antagonist oral anticoagulants received approval for reimbursement in Portugal for patients with non-valvular atrial fibrillation (AF). It is therefore important to evaluate the relative cost-effectiveness of these new oral anticoagulants in Portuguese AF patients...